|
2024
|
Invention
|
Biomarker for cytidine deaminase activity and use thereof. Provided are a biomarker for cytidine ... |
|
|
Invention
|
Universal influenza mrna vaccine and use thereof. Provided is a universal influenza mRNA vaccine.... |
|
2023
|
Invention
|
Method for detecting differentiated rna editing sites. A method for detecting differentiated RNA ... |
|
|
Invention
|
Anti-siglec15 antibodies and uses thereof.
This disclosure provides an anti-SIGLEC15 antibody, a... |
|
|
Invention
|
Anti-siglec15 antibodies and uses thereof. This disclosure provides an anti-SIGLEC15 antibody, an... |
|
2022
|
Invention
|
Antibody-drug conjugate and use thereof.
A linker, comprising an amino acid unit (RL). The RL co... |
|
|
Invention
|
Antibody-drug conjugate and use thereof. A linker, comprising an amino acid unit (RL). The RL com... |
|
|
Invention
|
Anti-cldn18.2 monoclonal antibody and use thereof. The present invention provides an anti-CLDN18.... |
|
|
Invention
|
Combined her2 and meso dual-target car-t vector, construction method therefor and application the... |
|
2019
|
Invention
|
Application of peg interferon and protooncogene product targeting inhibitor in synergistic treatm... |
|
|
Invention
|
Application of peg interferon and proto-oncogene product targeting inhibitor in synergistic treat... |
|
|
Invention
|
Application of peg-interferon and protooncogene product targeting inhibitor in synergistic inhibi... |
|
|
Invention
|
Anti-her3 humanized monoclonal antibody. Provided is an anti-HER3 humanized monoclonal antibody. ... |
|
2016
|
Invention
|
Mutant-type uricase, peg modified mutant-type uricase, and application thereof. A mutant-type uri... |
